(Q38137864)

English

Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.

scientific article published on 27 August 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

acute coronary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yangchun Liu

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Qiang Su

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Lang Li

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

27 August 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

36

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

E41-8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Frequency and long-term impact of myonecrosis after coronary stenting

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Coronary microembolization: from bedside to bench and back to bedside

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Microvascular obstruction: underlying pathophysiology and clinical diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Distal protection devices in primary percutaneous coronary intervention of native coronary artery lesions: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22198

21 January 2018

Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological management of no reflow during percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Essential messages from the ESC/EACTS guidelines on myocardial revascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment e

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24038054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.22198

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24038054%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38137864&oldid=1644891838"